Recent News

• 04.25.2025 - Celebrating DNA Day and the long-read sequencing tools moving genomics forward
• 04.22.2025 - Davos Alzheimer’s Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer’s Disease Research in North Africa
• 04.17.2025 - Customer success story: How SPRQ chemistry boosts data output across continents at Signios Biosciences
• 04.10.2025 - DNA extraction tips and best practices for HiFi sequencing
• 04.09.2025 - PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
• 04.04.2025 - PacBio Grants Equity Incentive Award to New Employee
• 04.03.2025 - Customer success story: The University of Bern takes long-read sequencing to the next level with SPRQ chemistry
• 03.27.2025 - Jim Gibson to join PacBio as Chief Financial Officer
• 03.27.2025 - Powered by PacBio:Selected publications from March 2025

Recent Filings

• 04.23.2025 - ARS Annual Report to Security Holders
• 04.23.2025 - DEF 14A Other definitive proxy statements
• 04.23.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.09.2025 - 8-K Current report
• 04.09.2025 - EX-99.1 EX-99.1
• 04.09.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.02.2025 - 3 Initial statement of beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.27.2025 - 8-K Current report